🇺🇸 FDA

Company profile · Sponsor

Parabilis

Parabilis Medicines

PBLS · NYSE pharma CAMBRIDGE, MA, USA
Pipeline
1
Drugs
0
Patents
1

Quick answer

Parabilis (PBLS) is a pharma company. headquartered in CAMBRIDGE, MA, USA. listed on NYSE. NovaPharmaNews links 1 pipeline program, 0 drugs, and 1 patent to this profile..

Company facts

Ticker PBLS
Exchange NYSE
Company type pharma
Headquarters CAMBRIDGE, MA, USA
SEC CIK 0001657677

Pipeline (1)

Search pipeline →

  1. FOG-001

    Parabilis

    Cancer

    phase 2 small molecule active

    1 trial

Patents (1)

Search patents →

  1. US 12398178

    Collections of peptides, peptide agents, and methods of use thereof

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Parabilis?

Parabilis (PBLS) is a pharma company. headquartered in CAMBRIDGE, MA, USA. listed on NYSE. NovaPharmaNews links 1 pipeline program, 0 drugs, and 1 patent to this profile..

What pipeline programs does Parabilis sponsor?

We track 1 ClinicalTrials.gov-linked program for Parabilis, including FOG-001. Open each program for phase, modality, NCT IDs, and indication details.

Where does Parabilis company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.